ÐÂÎÅ×ÊѶ
Z6ÈËÉú¾ÍÊDz©ÔÑÐÒ©MCR»·ëÄ¿ª±ÙÌÇÄò²¡ÊÓÍøĤ²¡±ä¶àͨ·ÖÎÁÆвßÂÔ£¬Í»ÆÆ¿¹VEGFÒ©Îï¾ÖÏÞ½ø¾üDZÔÚÊý°ÙÒÚÐÂÈüµÀ
ÈÕÆÚ£º
2026Äê04ÔÂ02ÈÕ 15:00
ÌÇÄò²¡ÊÓÍøĤ²¡±ä£¨DR£©ÊÇÌÇÄò²¡×î³£¼ûÇÒÑÏÖصÄ΢Ѫ¹Ü²¢·¢Ö¢Ö®Ò»£¬Ò²ÊǸ÷ÄêÁäÈËȺ£¨°üÀ¨¶ùͯ¡¢¹¤×÷³ÉÄêÈ˺ÍÀÏÄêÈË£©Ö÷ÒªµÄÖÂäÔÒò1¡£2020Ä꣬ȫÇòÓг¬¹ý1.03ÒÚÈËÊܵ½ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÓ°Ï죬Ԥ¼Æµ½2045ÄêÕâÒ»Êý×Ö½«ÉÏÉýµ½1.61ÒÚÈË1¡£ÕâÒ»ÑÓÐø¶àÄêµÄÁÙ´²ðó¼²£¬Õý±»Ò»ÏîÖйúÔ´´Í»ÆÆËùº³¶¯¡£½üÈÕ£¬¾ÝϤZ6ÈËÉú¾ÍÊDz©£¨ÒÔϼò³Æ“Z6ÈËÉú¾ÍÊDz©”£©×ÔÖ÷Ñз¢µÄ´´ÐÂС·Ö×Ó»·ëÄÒ©ÎMCR»·ëÄ£©ÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÖÎÁÆÁìÓòÈ¡µÃÁÙ´²Ç°ÖØ´óÍ»ÆÆ¡£
Ò»¡¢ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÖÎÁÆÀ§¾³
ÌÇÄò²¡ÊÓÍøĤ²¡±äÊÇÒ»ÖÖ½øÕ¹ÐÔÑÛ²¿¼²²¡£¬³¤ÆÚ¸ßѪÌǻᵼÖÂÊÓÍøĤ΢Ѫ¹ÜËðÉË£¬Òý·¢ÊÓÍøĤȱѪȱÑõ£¬½ø¶ø´Ù½ø²¡ÀíÐÔÐÂÉúѪ¹ÜÐγɣ¬Ôì³ÉÊÓÍøĤÔöÖ³ÐÔ²¡±ä2¡£Ä¿Ç°£¬¿¹VEGFÒ©ÎïºÍ¼¤¹â¹âÄýÊõÊÇÖÎÁÆDRµÄ½ð±ê×¼ÁÆ·¨£¬µ«´æÔÚÐèҪƵ·±ÑÛÄÚ×¢Éä¡¢²¿·Ö»¼ÕßÓ¦´ð²»¼ÑµÈÎÊÌ⣬ؽÐèÐÂÐÍÖÎÁƲßÂÔ1¡£
½üÄêÀ´µÄÑо¿·¢ÏÖ£¬ºÚƤÖÊËØϵͳ£¨Melanocortin System£©ÔÚµ÷½ÚÑ×Ö¢·´Ó¦¡¢´Ù½ø×éÖ¯ÐÞ¸´ºÍά³ÖÄÚ»·¾³Îȶ¨·½Ãæ·¢»Ó¹Ø¼ü×÷ÓÃ3£¬ÎªDRÖÎÁÆÌṩÁËÐÂ˼·¡£
¶þ¡¢Z6ÈËÉú¾ÍÊDz©MCR»·ëÄ£º¶ÔÊÓÍøĤ½á¹¹±£»¤Ð§¹ûÏÔÖø
Z6ÈËÉú¾ÍÊDz©Ñз¢µÄMCR»·ëÄÔÚDB/DBÌÇÄò²¡Ð¡ÊóÄ£ÐÍÖбíÏÖ³öÏÔÖøµÄÊÓÍøĤ±£»¤×÷Óá£
ʵÑé½á¹ûÏÔʾ£¬DB/DBÄ£ÐÍСÊóµÄÄں˲㣨INL£©ºÍÍâºË²ã£¨ONL£©ºñ¶ÈÃ÷ÏԱ䱡£¬ÕâÊÇÌÇÄò²¡ÒýÆðÊÓÍøĤ±äÐԵĵäÐÍÌØÕ÷¡£¶ø¾¹ýMCR»·ëÄÖÎÁƺó£¬ÊÓÍøĤ½á¹¹µÃµ½Ã÷ÏÔ¸ÄÉÆ£º
1. MCR»·ëĵͼÁÁ¿×éºÍ¸ß¼ÁÁ¿×éÏÔʾ¼ÁÁ¿ÒÀÀµÐÔµÄÊÓÍøĤ½á¹¹»Ö¸´£»
2. MCR»·ëĸ߼ÁÁ¿×éµÄONLºñ¶È»Ö¸´½Ó½üÕý³£Ë®Æ½¡£
Èý¡¢¶àÖØ»úÖÆÐͬ×÷ÓÃ
Z6ÈËÉú¾ÍÊDz©MCR»·ëĵĺËÐÄÓÅÊÆÔÚÓÚÆä¶à°Ðµã×÷ÓûúÖÆ¡£ËüÄ£ÄâÁËÄÚÔ´ÐÔºÚƤÖÊËØ£¨Èçα- MSH£©µÄÉúÀí¹¦ÄÜ£¬Í¨¹ý¼¤»îÑÛÖеĺÚƤÖÊËØÊÜÌ壬´ÓÑ×Ö¢¡¢Ñª¹Ü¡¢ÆÁÕϺÍÉñ¾µÈ¶à¸ö¹Ø¼ü»·½ÚÐͬ·¢»Ó×÷ÓÃ1, 4¡£
ǿЧ¿¹Ñ×ÓëÃâÒßµ÷½Ú
ÌÇÄò²¡ÊÓÍøĤ²¡±ä±¾ÖÊÉÏÊÇÒ»ÖÖÂýÐԵͶÈÑ×Ö¢ÐÔ¼²²¡¡£Ñо¿Ö¤Êµ£¬¼¤»îMCR£¬ÌرðÊÇMC1R£¬Äܹ»ÏÔÖøÒÖÖƺËÒò×ÓκB£¨NF-κB£©µÈ¹Ø¼ü´ÙÑ×ÐźÅͨ·µÄ»î»¯5¡£Õâµ¼Ö¶àÖÖ´ÙÑ×Òò×Ó£¨ÈçTNF-α, IL-1β, IL-6£©ºÍÇ÷»¯Òò×Ó£¨ÈçMIP-1α, MIP-2£©µÄ±í´ïϵ÷4¡£¸üÖØÒªµÄÊÇ£¬MCR¼¤¶¯¼ÁÄÜÓÕµ¼¾ßÓп¹Ñ×¹¦Äܵĵ÷½ÚÐÔTϸ°û£¨Treg£©µÄÉú³É£¬²¢´Ù½ø¿¹Ñ×ϸ°ûÒò×ÓIL-10µÄ±í´ï£¬´Ó¶ø½«ÃâÒß·´Ó¦´ÓÆÆ»µÐԵĴÙÑ×״̬תÏò±£»¤ÐԵĿ¹Ñ׺ÍÐÞ¸´×´Ì¬4, 5¡£´ËÍ⣬ÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÄ£ÐÍÖУ¬MCR¼¤¶¯¼Á»¹±»Ö¤Ã÷¿ÉÒÔ´Ù½ø¾ÞÊÉϸ°û´Ó´ÙÑ×µÄM1±íÐÍÏò¿¹Ñס¢´ÙÐÞ¸´µÄM2±íÐͼ«»¯£¬ÕâÓÐÖúÓÚÑ×Ö¢µÄÏûÍ˺Í×éÖ¯ÐÞ¸´4¡£
¿¹Ñª¹ÜÉú³ÉÓë¼õÇáÉø©
³ýÁËÒÖÖÆÑ×Ö¢£¬MCR¼¤¶¯¼ÁÄܹ»Ö±½Ó×÷ÓÃÓÚѪ¹Üϵͳ¡£Ñо¿±íÃ÷£¬¼¤»îMC4R¿ÉÒÔÞ׿¹ÊÓÍøĤ΢Ѫ¹ÜÄÚƤϸ°ûµÄ¸ßͨ͸ÐÔ5¡£Í¬Ê±£¬¼¤¶¯MC1RÄÜÏÔÖø½µµÍÊÓÍøĤÖÐѪ¹ÜÄÚƤÉú³¤Òò×Ó£¨VEGF£©µÄˮƽ£¬ÕâÊÇÇý¶¯²¡ÀíÐÔÐÂÉúѪ¹ÜÐγɺÍѪ¹ÜÉø©µÄ¹Ø¼üÒò×Ó4¡£ÕâÖÖͨ¹ýµ÷½ÚÄÚÔ´ÐÔͨ·À´ÒÖÖÆVEGFµÄ¶ÀÌØ»úÖÆ£¬ÓëÏÖÓеĿ¹VEGFÒ©ÎïÐγɻ¥²¹£¬¿ÉÄÜΪ½â¾ö¿¹VEGFÖÎÁÆÄÍÒ©ÐÔÎÊÌâÌṩвßÂÔ¡£
ÎȹÌѪ-ÊÓÍøĤÆÁÕÏ
Ѫ-ÊÓÍøĤÆÁÕϵÄÆÆ»µÊÇÌÇÄò²¡ÊÓÍøĤ²¡±äѪ¹ÜÉø©ºÍÊÓÍøĤˮÖ׵IJ¡Àí»ù´¡¡£MCR¼¤»î¿ÉÏÔÖøÔö¼ÓÊÓÍøĤÖнôÃÜÁ¬½Óµ°°×£¨ÈçOccludin£©µÄ±í´ï£¬´Ó¶ø´Ó½á¹¹ÉϼӹÌѪ-ÊÓÍøĤÆÁÕÏ£¬¼õÉÙѪ½¬³É·ÖµÄÉø©4¡£
Ö±½Óϸ°û±£»¤Ó뿹µòÍö
MCRµÄϸ°û±£»¤×÷Óó¬Ô½ÁËѪ¹ÜºÍÑ×֢ϸ°û£¬Ö±½Ó»Ý¼°ÊÓÍøĤÉñ¾Ôª¡£α-MSHÒѱ»Ö¤Ã÷Äܹ»Í¨¹ý¼¤»îMC1R¼°ÆäÏÂÓεÄAkt/mTORºÍErk1/2 MAPKÐźÅͨ·£¬±£»¤ÊÓÍøĤɫËØÉÏƤϸ°ûÃâÊÜÑõ»¯Ó¦¼¤ÓÕµ¼µÄµòÍö5¡£ÔÚȱѪ/ÔÙ¹à×¢ËðÉËÄ£ÐÍÖУ¬MCR¼¤¶¯¼ÁÏÔʾ³ö¶ÔÊÓÍøĤÉñ¾½Úϸ°ûµÄÏÔÖø±£»¤×÷Ó㬼õÉÙϸ°ûµòÍö£¬Õâ¶ÔÓÚ·ÀÖ¹ÌÇÄò²¡ÊÓÍøĤ²¡±äÖеÄÉñ¾±äÐÔÖÁ¹ØÖØÒª¡£
ËÄ¡¢Ç°¾°Õ¹Íû
ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÖÎÁÆÕý´¦ÔÚÒ»¸öתÐÍÆÚ£¬´Óµ¥Ò»µÄVEGFÒÖÖÆÏò¶à°Ðµã¡¢È«·½Î»±£»¤µÄ·½Ïò·¢Õ¹¡£Z6ÈËÉú¾ÍÊDz©µÄMCR»·ëÄÒ©Îïƾ½èÆä¶ÀÌصÄ×÷ÓûúÖƺÍÁîÈ˹ÄÎèµÄÁÙ´²Ç°Êý¾Ý£¬ÓÐÍû³ÉΪÕâÒ»ÁìÓòµÄÖØ°õ²úÆ·£¬ÎªÈ«ÇòÊýÒÚDR»¼Õß´øÀ´ÐµÄÖÎÁÆÑ¡Ôñ¡£
ÎÄÕÂÀ´Ô´ÓÚҩʱ´ú¹«ÖÚºÅ
²Î¿¼ÎÄÏ×
1. Seo, H., Park, S. J., & Song, M. (2025). Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies. Cells, 14(5), 376. https://doi.org/10.3390/cells14050376
2. áÓÖÝÉòÊÏÑÛ¿ÆÒ½Ôº£¨2024£©. ÌÇÄò²¡ÐÔÊÓÍøĤ²¡±ä¿ÆÆÕ. ΢ÐŹ«ÖÚºÅ. Available at:https://mp.weixin.qq.com/s?__biz=MzA5NDI4NTcyNw==&mid=2653585500&idx=1&sn=87cf362b3300a3db891c4c19b8296833&chksm=8a0f495e1bf34e32bdd0e087b3d55b6541aac5cd462a1dacdd8b0a2fc8e71fea61b44b2d1bb7&scene=27 £¨Accessed: September 28, 2025£©
3. Kayne, P. et al. (2025). Activating the Melanocortin System Resolves Inflammation, Reduces VEGF Signaling in Diabetic Retinopathy (DR), and Provides Retinal Ganglion Cell (RGC) Protection. Available at:https://palatin.com/wpcontent/uploads/2025/05/PosterPTN_PL9654_Diabetic_RetinopathyARVO_2025050825.pdf (Accessed: September 28, 2025)
4. Rossi, S., Maisto, R., Gesualdo, C., Trotta, M. C., Ferraraccio, F., Kaneva, M. K., Getting, S. J., Surace, E., Testa, F., Simonelli, F., Grieco, P., Merlino, F., Perretti, M., D'Amico, M., & Di Filippo, C. (2016). Activation of Melanocortin Receptors MC 1 and MC 5 Attenuates Retinal Damage in ExperimentalDiabeticRetinopathy. Mediatorsofinflammation,2016, 7368389. https://doi.org/10.1155/2016/7368389
5. Wang, S., Kahale, F., Naderi, A., Surico, P. L., Yin, J., Dohlman, T., Chen, Y., & Dana, R. (2024). Therapeutic Effects of Stimulating the Melanocortin Pathway in Regulating Ocular Inflammation and Cell Death.Biomolecules,14(2),169. https://doi.org/10.3390/biom14020169
Ïà¹ØÍƼö
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ̨ÖÝ